"Essentially every insurance carrier is just making it up, making up the policy, the limitation, the restriction on eligibility in the way that they want to, in a way that will kind of reduce the eligible population," Zvenyach says
One of the biggest reasons people quit taking GLP-1s is due to a lack of insurance in which case the drugs typically cost more than $1,000 per month
Retatrutide, often referred to as Triple G, is a new medication developed by Eli Lilly
For a blend, enter the total blend strength if you want total blend units, then interpret per-compound amounts according to the vial ratio
The Precision Peptide Genetic Test identifies your natural predispositions across 14 metabolic pathways and 49 peptides, including key variants like GLP1R rs6923761 and GIPR rs1800437 that directly influence semaglutide responsiveness